BioCentury This Week is hosted by Washington Editor Steve Usdin and Publisher Eric
Pierce, both 21 year veterans of BioCentury. They are supported by BioCentury's
network of senior scientific and business editors recognized for their deep knowledge
and understanding of biotechnology: its science, its history and its players.
BioCentury This Week programming is overseen by BioCentury's founders, Chairman
& Editor-in-Chief Karen Bernstein, Ph.D., and President & CEO David Flores, both
globally recognized for their efforts to provide an objective, accurate and authoritative
information platform for key decision makers in bioindustry.
BioCentury This Week Anchors
Senior Editor, Washington
Steve has been Washington Editor of BioCentury since 1993, and has spent the past 20 years in the nation's capital covering political and policy issues affecting the life sciences sector. He also is the host of BioCentury This Week, BioCentury's weekly public affairs television program, as well as BioCentury Senior Editor responsible for coverage of social issues involving biotechnology. Steve’s reporting about biotechnology and biomedical policy has been cited in The Economist, The Wall Street Journal, the Washington Post, New Scientist and other publications.
In 2012, the FDA Alumni Association named Steve the Harvey W. Wiley Lecturer, making him the first journalist to receive the Wiley Award. His book, “Engineering Communism: How Two Americans Spied for Stalin and Founded the Soviet Silicon Valley,” was published in 2005 by Yale University Press.
Eric joined BioCentury in 1993 as its first Staff Writer, and became chief financial writer in 1996 when he originated "Ebb & Flow," BioCentury's weekly capital markets column. As Senior Editor for News, Eric managed BioCentury's news operations until 2004, when he joined the management team as Associate Publisher, and in 2007 was named Publisher. He holds an A.B. in Communication from Stanford University and completed graduate studies at the Mass Media Institute at Stanford, with an emphasis on broadcast journalism.
Erin joined BioCentury in 2008. She previously was a program officer at The Great Lakes Protection Fund and a biologist at Dow AgroSciences LLC. She holds an M.Sc. in environmental science and policy from the University of Chicago and a B.S. in biology from Purdue University.
BioCentury This Week Executive Editors
BioCentury This Week Executive Editors
Co-Founder, President & CEO
David has devoted more than 25 years to developing information products for biotechnology executives and investors. He is a graduate of the University of California at Berkeley and holds an MBA from Stanford University. David is a member of the Advisory Board of the Innovation and New Ventures Office (INVO) at Northwestern University and a member of the Advisory Council of the Keck Graduate Institute of the Applied Life Sciences.
He also has served as a member of the Stanford Graduate School of Business Management Board. In 1996, David and BioCentury Co-Founder, Chairman & Editor-in-Chief Karen Bernstein were honored with the Special Recognition Award given by the annual gathering of biotechnology chief executive officers in Laguna Niguel, Calif., citing BioCentury's ongoing contributions to the industry.
Co-Founder, Chairman & Editor-in-Chief
Karen has been writing and publishing on biotechnology since 1987. She holds a Ph.D. in political science from Stanford University and a B.A. in politics and history from Brandeis University, where she served for many years as a member of the Brandeis University Science Advisory Council. She is on the board of trustees of the Keck Graduate Institute of the Applied Life Sciences and is a member of the board of advisors of KGI's School of Pharmacy.
In 2005, the annual gathering of biotechnology chief executive officers at The Biotech Meeting in Laguna Niguel, Calif., inducted Karen into their Hall of Fame, citing her lifetime contribution to the biotech community. In 2007, Karen received a Special Recognition award at the American Liver Foundation's Salute to Excellence, honoring individuals who have made an outstanding contribution to biotechnology and medical innovation.